Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis

Clinical Cancer Research

Volumn 9, Issue 9, 2003, Pages 3454-3461

  Alvarez, Enrique ^a   Fey, Edward G ^b   Valax, Pascal ^a   Yim, Zachary ^a   Peterson, Jeffrey D ^a   Mesri, Medhi ^a   Jeffers, Michael ^a   Dindinger, Matthew ^a   Twomlow, Nancy ^a   Ghatpande, Ashwini ^a   LaRochelle, William J ^a   Sonis, Stephen T ^c   Lichenstein, Henri S ^a  

^a CURAGEN CORPORATION   (United States)

^b Biomodels LLC   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CG 53135; MITOGENIC AGENT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEEK POUCH; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; EPITHELIUM CELL; HAMSTER; IN VIVO STUDY; JEJUNUM; MALE; MESENCHYME CELL; MITOGENESIS; MOUTH MUCOSA; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY;

ANIMALS; BROMODEOXYURIDINE; CHEEK; COLORING AGENTS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTORS; FLUOROURACIL; HUMANS; JEJUNUM; MALE; MESOCRICETUS; MOUTH MUCOSA; MUCOUS MEMBRANE; RADIATION INJURIES; RECOMBINANT PROTEINS; STOMATITIS; TIME FACTORS;

EID: 10744231812     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sonis, S. T., Oster, G., Fuchs, H., Bellm, L., Bradford, W. Z., Edelsberg, J., Hayden, V., Eilers, J., Epstein, J. B., LeVeque, F. G., Miller, C., Peterson, D. E., Schubert, M. M., Spijkervet, F. K., and Horowitz, M. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J. Clin. Oncol., 19: 2201-2205, 2001.
2. Plevova, P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncol., 35: 453-470, 1999.
3. Stiff, P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant., 27: S3-S11, 2001.
4. Epstein, J. B., and Schubert, M. M. Oral mucositis in myelosuppressive cancer therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 88: 273-276, 1998.
5. Knox, J. J., Puodziunas, A. L., and Feld, R. Chemotherapy-induced oral mucositis. Prevention and management. Drugs Aging, 17: 257-267, 2000.
6. Dodd, M. J., Larson, P. J., Dibble, S. L., Miaskowski, C., Greenspan, D., ManPhail, L., Hauck, W. W., Paul, S. M., Ignoffo, R., and Shiba, G. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol. Nurs. Forum, 23: 921-927, 1996.
7. Dodd, M. J., Larson, P. J., Dibble, S. L., Miaskowski, C., ManPhail, L., Greenspan, D., Paul, S. M., Shiba, G., and Larson, P. Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 90: 39-47, 2000.
8. Antin, J. H., Lee, S. J., Neuberg, D., Alyea, E., Soiffer, R. J., Sonis, S., and Ferrara, J. L. A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. Bone Marrow Transplant., 29: 373-377, 2002.
9. Wymenga, A. N., van der Graaf, W. T., Hofstra, L. S., Spijkervet, F. K., Timens, W., Timmer-Bosscha, H., Sluiter, W. J., Van Buuren, A. H., Mulder, N. H., and de Vries, E. G. E. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis. Clin. Cancer Res., 5: 1363-1368, 1999.
10. Katano, M., Nakamura, M., Matsuo, T., Iyama, A., and Hisatsugu, T. Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis. Surg. Today, 25: 202-206, 1995.
11. Bez, C., Demarosi, F., Sardella, A., Lodi, G., Bertolli, V. G., Annaloro, C., Rimondini, L., Porter, S. R., and Carrassi, A. GM-CSF mouthrinses in the treatment of severe oral mucositis: a pilot study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 88: 311-315, 1999.
12. Karthaus, M., Rosenthal, C., Huebner, G., Paul, H., Elser, C., Hertenstein, B., Krauter, J., Scharmann, T., Geissler, R. G., Heil, G., and Ganser, A. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial. Bone Marrow Transplant., 22: 781-785, 1998.
13. Danilenko, D. M. Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol. Pathol., 27: 64-71, 1999.
14. Chi, K. H., Chen, C. H., Chan, W. K., Chow, K. C., Chen, S. Y., Yen, S. H., Chao, J. Y., Chang, C. Y., and Chen, K. Y. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluoracil, and leucovorin chemotherapy. J. Clin. Oncol., 13: 2620-2628, 1995.
15. Peterson, D. E. Research advances in Oral Mucositis. Curr. Opin. Oncol., 11: 261-266, 1999.
16. Sonis, S. T. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol., 34: 39-43, 1998.
17. Paris, F., Fuks, Z., Kang, A., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz-Friedman, A., Cordon-Cardo, C., and Kolesnick, R. Endothelial apoptosis as the primary lesion intiating intestinal radiation damage in mice. Science (Wash. DC), 293: 293-297, 2001.
18. Sonis, S. T., Scherer, J., Phelan, S., Lucey, C. A., Barron, J. E., O'Donnell, K. E., Brennan, R. J., Pan, H., Busse, P., and Haley, J. D. The gene expression sequence of radiated mucosa in an animal mucositis model. Cell Prolif., 35: 93-102, 2002.
19. Sengel, P. Pattern formation in skin development. Int. J. Dev. Biol., 34: 33-50, 1990.
20. Farrell, C. L., Bready, J. V., Rex, K. L., Chen, J. N., DiPalma, C. R., Whitcomb, K. L., Yin, S., Hill, D. C., Wiemann, B., Starnes, C. O., Havill, A. M., Lu, Z. N., Aukerman, S. L., Pierce, G. F., Thomason, A., Potten, C. S., Ulrich, T. R., and Lacey, D. L. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res., 58: 933-939, 1998.
21. Farrell, C. L., Rex, K. L., Chen, J. N., Bready, J. V., DiPalma, C. R., Kaufman, S. A., Rattan, A., Scully, S., and Lacey, D. L. The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif., 35: 78-85, 2002.
22. Jeffers, M., Shimkets, R., Prayaga, S., Boldog, F., Yang, M., Burgess, C., Fernandes, E., Rittman, B., Shimkets, J., LaRochelle, W. J., and Lichenstein, H. S. Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis. Cancer Res., 61: 3131-3138, 2001.
23. Jeffers, M., McDonald, W. F., Chillakuru, R. A., Yang, M., Nakase, H., Deegler, L. L., Sylander, E. D., Rittman, B., Bendele, A., Sartor, R. B., and Lichenstein, H. S. A novel human fibroblast growth factor treats experimental intestinal inflammation. gastroenterology, 123: 1151-1162, 2002.
24. Sonis, S. T., Tracey, C., Shklar, G., Jenson, J., and Florine, D. An animal model for mucositis induced by cancer chemotherapy. Oral Surg. Oral Med. Oral Pathol., 69: 437-443, 1990.
25. Sonis, S. T. (ed.). Animal Models of Oral Mucositis Induced by Antineoplastic Drugs and Radiation p323-335 Tumor Models in Cancer Research. Totowa, NJ: Humana Press, Beverly Teicher, 2002.